A comprehensive guide to primary hypogonadism, age-related testosterone decline ("manopause"), and how Testosterone Replacement Therapy can help restore quality of life.
Testosterone is the primary male sex hormone and anabolic steroid. It plays a critical role in the development of male reproductive tissues and promotes secondary sexual characteristics such as increased muscle and bone mass, and the growth of body hair.
Beyond its role in reproduction, testosterone is vital for overall health and well-being. It influences mood, energy levels, cognitive function, cardiovascular health, and body composition throughout a man's life.
Testosterone is produced primarily in the testes, regulated by a complex feedback loop known as the Hypothalamic-Pituitary-Gonadal (HPG) axis.

The HPG Axis — Hormonal Feedback Loop
The hypothalamus releases Gonadotropin-Releasing Hormone (GnRH) in a pulsatile fashion, signalling the pituitary gland to produce gonadotropins.
In response to GnRH, the anterior pituitary releases Luteinising Hormone (LH) and Follicle-Stimulating Hormone (FSH) into the bloodstream.
LH stimulates the Leydig cells in the testes to produce testosterone. FSH supports spermatogenesis. Testosterone feeds back to the hypothalamus and pituitary to regulate production.
Primary hypogonadism (also called hypergonadotropic hypogonadism) occurs when the testes themselves fail to produce adequate testosterone, despite receiving appropriate signals from the pituitary gland.
In this condition, LH and FSH levels are typically elevated — the brain is "shouting louder" at the testes to produce testosterone, but the testes cannot respond adequately.
Primary (Testicular Failure)
Low testosterone + High LH/FSH
The problem originates in the testes
Secondary (Central/Pituitary)
Low testosterone + Low/Normal LH/FSH
The problem originates in the hypothalamus or pituitary
Age-Related Decline in Total Testosterone
Estimated mean total testosterone (ng/dL) by age
Modelled on data from Feldman et al. (2002) — ~1.6% annual decline in total testosterone.
Red dashed line indicates the clinical threshold for testosterone deficiency (~300 ng/dL).
Unlike female menopause, which involves a relatively abrupt decline in hormones, andropause (commonly called "manopause" or "male menopause") is characterised by a gradual, progressive decline in testosterone levels.
The landmark Massachusetts Male Aging Study (MMAS) — a large population-based prospective study — demonstrated that total testosterone declines at a rate of approximately1.6% per year, while free and albumin-bound testosterone decline even more steeply at 2–3% per year (Feldman et al., 2002).
This age-related decline is now recognised as Late-Onset Hypogonadism (LOH) — a legitimate clinical condition that can profoundly impact quality of life, physical health, and mental well-being. The MMAS data showed that by age 70, the average man's total testosterone has fallen to roughly half of peak levels.
It's important to note that not all men will experience symptomatic testosterone deficiency — lifestyle factors including sleep, exercise, stress management, and body composition play a significant role in testosterone levels.
Low testosterone can manifest across physical, psychological, and sexual domains. Symptoms are often gradual and may be attributed to "normal ageing."

Testosterone Replacement Therapy aims to restore testosterone levels to the physiological range, alleviating symptoms and improving quality of life. Several delivery methods exist — but not all are equal.
Intramuscular testosterone injection — typically Testosterone Cypionate or Enanthate — is widely regarded as the gold standard of TRT delivery. Here's why:
At Enhanced TRT, intramuscular injection is our primary recommended protocol. We use pharmaceutical-grade Testosterone Cypionate with individualised dosing schedules to achieve optimal, stable serum levels.
Applied daily to the skin. Can provide steady-state levels but requires strict daily compliance, has variable absorption rates (especially with sweating or showering), and carries a significant risk of transference to others via skin contact.
Lower-volume, more frequent injections using smaller needles into fatty tissue. May suit patients who prefer smaller needles, though absorption can be less predictable than intramuscular delivery.
Worn on the skin daily. Often cause local skin irritation and adhesion issues. Absorption varies widely between individuals and is affected by body hair and perspiration.
Surgically implanted subcutaneously every 3–6 months. Provide long-acting release but require a minor procedure, carry infection risk, and dosing cannot be easily adjusted once implanted.

Common TRT delivery methods
Safe TRT requires regular blood work and clinical review to ensure optimal outcomes and minimise risks.
Total and free testosterone to ensure therapeutic range
Monitor for polycythaemia (elevated red blood cells)
Prostate-specific antigen screening for prostate safety
Monitor oestrogen conversion and manage side effects
Hepatic markers to assess metabolic impact
Cholesterol and triglyceride monitoring
Subjective well-being, libido, energy assessment
Blood pressure, heart rate, and risk factor assessment
Start with our free Aging Males' Symptoms questionnaire to assess your risk, or book a confidential telehealth consultation.